IAEA's role in the global management of cancer-focus on upgrading radiotherapy services
- 1 January 2005
- journal article
- review article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 44 (8) , 816-824
- https://doi.org/10.1080/02841860500341355
Abstract
The International Atomic Energy Agency (IAEA) is an intergovernmental organization composed by 138 Member States within the United Nations. It has a mandate to seek to accelerate and enlarge the contribution of atomic energy to peace, health and prosperity throughout the world. Within the IAEA structure, the Division of Human Health contributes to the enhancement of the capabilities in Member States to address needs related to prevention, diagnosis and treatment of health problems through the development and application of nuclear and radiation techniques within a framework of quality assurance. In view of the increasing cancer incidence rates in developing countries the activities in improving management of cancer have become increasingly important. This review will outline the IAEA's role in cancer management focusing on activities related to improving radiotherapy worldwide.Keywords
This publication has 14 references indexed in Scilit:
- Developed world is robbing African countries of health staffBMJ, 2005
- Research and Development of Radiation Therapy in Clinical RoutinesActa Oncologica, 2003
- The Swedish Council on Technology Assessment in Health Care (SBU) Systematic Overview of Radiotherapy for Cancer including a Prospective Survey of Radiotherapy Practice in Sweden 2001--Summary and ConclusionsActa Oncologica, 2003
- Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma—an International Atomic Energy Agency studyInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Radiotherapy services in countries in transition: gross national income per capita as a significant factorRadiotherapy and Oncology, 2002
- Swedish Cancer Society Radiation Therapy Research InvestigationActa Oncologica, 2002
- Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of CancerEuropean Journal Of Cancer, 2000
- The IAEA/WHO TLD postal programme for radiotherapy hospitalsRadiotherapy and Oncology, 2000
- The European UnionPublished by Springer Nature ,1997
- Quality assurance in radiotherapy: European Society for Therapeutic Radiology and Oncology Advisory Report to the Commission of the European Union for the ‘Europe Against Cancer Programme’Radiotherapy and Oncology, 1995